- Abbott's FreeStyle Libre honored as the "best of the best"
since 1970 during the Prix Galien Golden Jubilee Awards
- Revolutionary FreeStyle Libre technology has transformed the
lives of approximately 4.5 million people1 living with
diabetes globally
ABBOTT
PARK, Ill., Oct. 28,
2022 /PRNewswire/ -- The Galien Foundation, the
premier global institution dedicated to honoring innovators in life
sciences, named Abbott's FreeStyle Libre® continuous
glucose monitoring technology as the "Best Medical Technology" of
the last 50 years during its Prix Galien Golden Jubilee Awards
ceremony on Oct. 27 in New York City. The Prix Galien Golden Jubilee
Awards recognize global innovations that have had the greatest
impact on society since the Galien Foundation was founded in
1970.
Award winners were chosen across five categories from the 250
products awarded the Prix Galien, regarded as the equivalent of the
Nobel Prize for biopharmaceutical and medical technology research,
between 1970 and 2019. The FreeStyle Libre system was awarded the
2019 Prix Galien USA Award for
Best Medical Technology.
"Abbott's FreeStyle Libre portfolio has revolutionized how
people live with diabetes, eliminating the need for traditional
fingersticks," said Jared Watkin,
senior vice president of Abbott's diabetes care business. "Today,
approximately 4.5 million people around the world use this
life-changing technology to manage their diabetes and improve
health outcomes, helping them live fuller, healthier lives every
day."
"The Prix Galien Golden Jubilee Awards honor the global 'best of
the best' innovations that have improved the human condition over
the last 50 years," said Bruno
Cohen, Chairman of the Galien Foundation. "The companies
behind these amazing innovations have a bold passion for change,
which has led to the development of life-saving products."
Over the years, Abbott has received 11 Prix Galien Awards for
its innovations in pharmaceuticals and medical technology,
including for Humira, MitraClip™ and FreeStyle Libre.
About Abbott:
Abbott is a global healthcare leader
that helps people live more fully at all stages of life. Our
portfolio of life-changing technologies spans the spectrum of
healthcare, with leading businesses and products in diagnostics,
medical devices, nutritionals and branded generic medicines. Our
113,000 colleagues serve people in more than 160 countries.
Connect with Abbott at www.abbott.com, on LinkedIn
at www.linkedin.com/company/abbott, on Facebook
at www.facebook.com/Abbott and on
Twitter @AbbottNews.
Indications and Important Safety Information
FreeStyle Libre 14 day system: Failure to use
FreeStyle Libre 14 day system as instructed in labeling may result
in missing a severe low or high glucose event and/or making a
treatment decision, resulting in injury. If readings do not match
symptoms or expectations, use a fingerstick value from a blood
glucose meter for treatment decisions. Seek medical attention when
appropriate or contact Abbott
at 855-632-8658 or FreeStyleLibre.us for safety
info.
FreeStyle Libre 2 and FreeStyle Libre 3
systems: Failure to use FreeStyle Libre 2 or FreeStyle
Libre 3 systems as instructed in labeling may result in missing a
severe low or high glucose event and/or making a treatment
decision, resulting in injury. If glucose alarms and readings do
not match symptoms or expectations, use a fingerstick value from a
blood glucose meter for treatment decisions. Seek medical attention
when appropriate or contact Abbott
at 855-632-8658 or FreeStyleLibre.us for safety
info.
For U.S. important safety information on MitraClip,
visit http://abbo.tt/MitraClipG4ISI.
1 Data on file, Abbott Diabetes Care. Data based on
the number of users worldwide for the FreeStyle Libre portfolio
compared to the number of users for other leading personal use,
sensor-based glucose monitoring systems.
2 Data on file, Abbott Diabetes Care. Fingersticks
are required for treatment decisions when you see Check Blood
Glucose symbol, when symptoms do not match system readings, when
you suspect readings may be inaccurate, or when you experience
symptoms that may be due to high or low blood glucose.
View original
content:https://www.prnewswire.com/news-releases/abbotts-freestyle-libre-is-named-best-medical-technology-in-last-50-years-by-the-galien-foundation-301662009.html
SOURCE Abbott